First-line treatment of metastatic breast cancer with weekly abraxane (nab-paclitaxel: a 130 nm albumin-bound paclitaxel particle): A preliminary analysis of the phase II international oncology network ION-04-012 study

B. Mirtsching,T. Chidiac,T. Cosgriff

First-line treatment of metastatic breast cancer with weekly abraxane (nab-paclitaxel: a 130 nm albumin-bound paclitaxel particle): A preliminary analysis of the phase II international oncology network ION-04-012 study

2006

B. Mirtsching
T. Chidiac
T. Cosgriff

10707 Background: Abraxane (paclitaxel protein-bound particles) by intravenous weekly administration schedule has been demonstrated to be active and well tolerated in patients with metastatic breas...

Keywords:

Nab-paclitaxel
Oncology
130-nm albumin-bound paclitaxel
Metastatic breast cancer
Chemistry
Internal medicine
first line treatment
in patient
preliminary analysis
Paclitaxel
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations